Cargando…
Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
[Image: see text] We herein report the design and synthesis of the first nanomolar binding inhibitor of STAT5 protein. Lead compound 13a, possessing a phosphotyrosyl-mimicking salicylic acid group, potently and selectively binds to STAT5 over STAT3, inhibits STAT5–SH2 domain complexation events in v...
Autores principales: | Cumaraswamy, Abbarna A., Lewis, Andrew M., Geletu, Mulu, Todic, Aleksandra, Diaz, Diego B., Cheng, Xin Ran, Brown, Carla E., Laister, Rob C., Muench, David, Kerman, Kagan, Grimes, H. Leighton, Minden, Mark D., Gunning, Patrick T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234445/ https://www.ncbi.nlm.nih.gov/pubmed/25419444 http://dx.doi.org/10.1021/ml500165r |
Ejemplares similares
-
PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication
por: Geletu, Mulu, et al.
Publicado: (2019) -
Anticancer metallohelices: nanomolar potency and high selectivity
por: Kaner, Rebecca A., et al.
Publicado: (2016) -
Discovery
of Desmuramylpeptide NOD2 Agonists with
Single-Digit Nanomolar Potency
por: Guzelj, Samo, et al.
Publicado: (2022) -
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
por: Gleixner, Karoline V., et al.
Publicado: (2017) -
Stat3 and Gap Junctions in Normal and Lung Cancer Cells
por: Guy, Stephanie, et al.
Publicado: (2014)